Close
Back to CRTX Stock Lookup

Cortexyme (CRTX) – Management Comments

Feb 1, 2022 08:01 AM Cortexyme (CRTX) Issues Pipeline Update and Anticipated 2022 Milestones
Dec 4, 2020 07:01 AM Cortexyme (CRTX) Reports Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis
Feb 13, 2020 08:26 AM
Jan 13, 2020 08:08 AM
Nov 7, 2013 07:09 AM

Back to CRTX Stock Lookup